Clorox Co (NYSE:CLX) SVP Diego J. Barral sold 12,880 shares of the business’s stock in a transaction on Tuesday, November 6th. The shares were sold at an average price of $157.98, for a total transaction of $2,034,782.40. Following the completion of the transaction, the senior vice president now directly owns 18,603 shares in the company, valued at $2,938,901.94. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Shares of NYSE:CLX traded down $0.93 on Thursday, reaching $157.74. 786,037 shares of the company were exchanged, compared to its average volume of 1,204,872. The company has a quick ratio of 0.65, a current ratio of 1.07 and a debt-to-equity ratio of 3.38. Clorox Co has a 1-year low of $113.57 and a 1-year high of $158.87. The stock has a market cap of $20.18 billion, a PE ratio of 25.20, a price-to-earnings-growth ratio of 3.88 and a beta of 0.28.
Clorox (NYSE:CLX) last posted its quarterly earnings results on Wednesday, October 31st. The company reported $1.62 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.59 by $0.03. Clorox had a net margin of 13.59% and a return on equity of 102.65%. The business had revenue of $1.56 billion for the quarter, compared to analysts’ expectations of $1.53 billion. During the same period in the prior year, the company posted $1.46 EPS. The business’s revenue for the quarter was up 4.2% on a year-over-year basis. Equities analysts anticipate that Clorox Co will post 6.31 earnings per share for the current year.
Several large investors have recently bought and sold shares of CLX. Millennium Management LLC grew its stake in shares of Clorox by 539.2% during the 1st quarter. Millennium Management LLC now owns 63,727 shares of the company’s stock worth $8,483,000 after purchasing an additional 53,757 shares during the period. Allianz Asset Management GmbH boosted its position in shares of Clorox by 7.3% in the 1st quarter. Allianz Asset Management GmbH now owns 27,271 shares of the company’s stock worth $3,630,000 after buying an additional 1,848 shares in the last quarter. DnB Asset Management AS boosted its position in shares of Clorox by 3.8% in the 2nd quarter. DnB Asset Management AS now owns 16,540 shares of the company’s stock worth $2,237,000 after buying an additional 600 shares in the last quarter. IFM Investors Pty Ltd boosted its position in shares of Clorox by 39.3% in the 2nd quarter. IFM Investors Pty Ltd now owns 5,795 shares of the company’s stock worth $784,000 after buying an additional 1,636 shares in the last quarter. Finally, Fisher Asset Management LLC boosted its position in shares of Clorox by 2.1% in the 2nd quarter. Fisher Asset Management LLC now owns 32,473 shares of the company’s stock worth $4,392,000 after buying an additional 662 shares in the last quarter. 78.35% of the stock is currently owned by institutional investors and hedge funds.
Several equities analysts have issued reports on CLX shares. Bank of America boosted their price objective on shares of Clorox from $130.00 to $140.00 and gave the company a “neutral” rating in a research note on Monday, July 16th. Goldman Sachs Group cut shares of Clorox from a “neutral” rating to a “sell” rating and dropped their price objective for the company from $127.00 to $112.00 in a research note on Tuesday, July 17th. They noted that the move was a valuation call. UBS Group started coverage on shares of Clorox in a research note on Wednesday, July 18th. They issued a “sell” rating and a $110.00 price objective on the stock. BMO Capital Markets reissued a “buy” rating and issued a $153.00 price objective on shares of Clorox in a research note on Friday, August 3rd. Finally, Atlantic Securities started coverage on shares of Clorox in a research note on Thursday, September 20th. They issued a “neutral” rating and a $151.00 price objective on the stock. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and four have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $141.64.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Article: Why is Cost of Capital Important?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.